866-997-4948(US-Canada Toll Free)

BIOCRATES Life Sciences AG - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 34 Pages


Summary

BIOCRATES Life Sciences AG, (BIOCRATES) is a medical device company, based in Austria. The company develops kits, software and services for targeted metabolomics. Its products include sterolDQ kit, absoluteDQ kit and metadislDQ kit. BIOCRATES provides metabolic services in the medical fields of oncology, stroke, nephrology, diabetes and sepsis. The company is partnered with pharmaceutical, biotechnology and nutrition companies. It is ISO 9000:2001 certified. The company operates through its distribution network in Denmark, Spain, Sweden, Finland, Norway and Iceland. BIOCRATES is headquartered Innsbruck, Austria.

This report is a source for data, analysis and actionable intelligence on the BIOCRATES Life Sciences AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.

Table of Contents 2
List of Tables 4
List of Figures 5
Key Facts 6
BIOCRATES Life Sciences AG - Major Products and Services 7
BIOCRATES Life Sciences AG Pipeline Products by Equipment Type 8
BIOCRATES Life Sciences AG Pipeline Products by Development Stage 10
BIOCRATES Life Sciences AG Pipeline Products by Therapy Area 12
Companion Diagnostic Test - Cancer 14
Companion Diagnostic Test - Cancer Product Status 14
Companion Diagnostic Test - Cancer Product Description 14
Companion Diagnostic Test - Diabetes 15
Companion Diagnostic Test - Diabetes Product Status 15
Companion Diagnostic Test - Diabetes Product Description 15
Companion Diagnostic Test - Kidney Disease 16
Companion Diagnostic Test - Kidney Disease Product Status 16
Companion Diagnostic Test - Kidney Disease Product Description 16
Companion Diagnostic Test - Sepsis 17
Companion Diagnostic Test - Sepsis Product Status 17
Companion Diagnostic Test - Sepsis Product Description 17
Companion Diagnostic Test - Stroke 18
Companion Diagnostic Test - Stroke Product Status 18
Companion Diagnostic Test - Stroke Product Description 18
Metabolomic Biomarker Assay - Breast Cancer 19
Metabolomic Biomarker Assay - Breast Cancer Product Status 19
Metabolomic Biomarker Assay - Breast Cancer Product Description 19
Metabolomic Biomarker Assay - Breast Cancer Product Patent Details 19
Metabolomic Biomarker Assay - COPD 21
Metabolomic Biomarker Assay - COPD Product Status 21
Metabolomic Biomarker Assay - COPD Product Description 21
Metabolomic Biomarker Assay - COPD Product Patent Details 21
Metabolomic Biomarker Assay - Diabetes 23
Metabolomic Biomarker Assay - Diabetes Product Status 23
Metabolomic Biomarker Assay - Diabetes Product Description 23
Metabolomic Biomarker Assay - Kidney Disease 24
Metabolomic Biomarker Assay - Kidney Disease Product Status 24
Metabolomic Biomarker Assay - Kidney Disease Product Description 24
Metabolomic Biomarker Assay - Prostate Cancer 25
Metabolomic Biomarker Assay - Prostate Cancer Product Status 25
Metabolomic Biomarker Assay - Prostate Cancer Product Description 25
Metabolomic Biomarker Assay - Sepsis 26
Metabolomic Biomarker Assay - Sepsis Product Status 26
Metabolomic Biomarker Assay - Sepsis Product Description 26
Metabolomic Biomarker Assay - Steatohepatitis 27
Metabolomic Biomarker Assay - Steatohepatitis Product Status 27
Metabolomic Biomarker Assay - Steatohepatitis Product Description 27
Metabolomic Biomarker Assay - Steatohepatitis Product Patent Details 27
Metabolomic Biomarker Assay - Stroke 29
Metabolomic Biomarker Assay - Stroke Product Status 29
Metabolomic Biomarker Assay - Stroke Product Description 29
BIOCRATES Life Sciences AG - Key Competitors 30
BIOCRATES Life Sciences AG - Key Employees 31
BIOCRATES Life Sciences AG - Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
BIOCRATES Life Sciences AG, Recent Developments 33
Sep 26, 2012: Biocrates Launches Full Set Of Reagents For MS-Based Steroid Analysis 33

Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Table


BIOCRATES Life Sciences AG, Key Facts 1
BIOCRATES Life Sciences AG Key Pipeline Products by Equipment Type 1
BIOCRATES Life Sciences AG Key Pipeline Products by Therapy Area 1
BIOCRATES Life Sciences AG Key Pipeline Products by Development Stage 1
BIOCRATES Life Sciences AG, Key Facts 6
BIOCRATES Life Sciences AG, Major Products and Services 7
BIOCRATES Life Sciences AG Number of Pipeline Products by Equipment Type 8
BIOCRATES Life Sciences AG Pipeline Products by Equipment Type 9
BIOCRATES Life Sciences AG Number of Pipeline Products by Development Stage 10
BIOCRATES Life Sciences AG Pipeline Products by Development Stage 11
BIOCRATES Life Sciences AG Number of Pipeline Products by Therapy Area 12
BIOCRATES Life Sciences AG Pipeline Products by Therapy Area 13
Companion Diagnostic Test - Cancer - Product Status 14
Companion Diagnostic Test - Cancer - Product Description 14
Companion Diagnostic Test - Diabetes - Product Status 15
Companion Diagnostic Test - Diabetes - Product Description 15
Companion Diagnostic Test - Kidney Disease - Product Status 16
Companion Diagnostic Test - Kidney Disease - Product Description 16
Companion Diagnostic Test - Sepsis - Product Status 17
Companion Diagnostic Test - Sepsis - Product Description 17
Companion Diagnostic Test - Stroke - Product Status 18
Companion Diagnostic Test - Stroke - Product Description 18
Metabolomic Biomarker Assay - Breast Cancer - Product Status 19
Metabolomic Biomarker Assay - Breast Cancer - Product Description 19
Metabolomic Biomarker Assay - Breast Cancer - Patent Details1 19
Metabolomic Biomarker Assay - COPD - Product Status 21
Metabolomic Biomarker Assay - COPD - Product Description 21
Metabolomic Biomarker Assay - COPD - Patent Details1 21
Metabolomic Biomarker Assay - Diabetes - Product Status 23
Metabolomic Biomarker Assay - Diabetes - Product Description 23
Metabolomic Biomarker Assay - Kidney Disease - Product Status 24
Metabolomic Biomarker Assay - Kidney Disease - Product Description 24
Metabolomic Biomarker Assay - Prostate Cancer - Product Status 25
Metabolomic Biomarker Assay - Prostate Cancer - Product Description 25
Metabolomic Biomarker Assay - Sepsis - Product Status 26
Metabolomic Biomarker Assay - Sepsis - Product Description 26
Metabolomic Biomarker Assay - Steatohepatitis - Product Status 27
Metabolomic Biomarker Assay - Steatohepatitis - Product Description 27
Metabolomic Biomarker Assay - Steatohepatitis - Patent Details1 27
Metabolomic Biomarker Assay - Stroke - Product Status 29
Metabolomic Biomarker Assay - Stroke - Product Description 29
BIOCRATES Life Sciences AG, Key Employees 31

List of Chart


BIOCRATES Life Sciences AG Key Pipeline Products by Equipment Type 1
BIOCRATES Life Sciences AG Pipeline Products by Equipment Type 8
BIOCRATES Life Sciences AG Pipeline Products by Development Stage 10
BIOCRATES Life Sciences AG Pipeline Products by Therapy Area 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *